5-BroMo-3,4-difluorobenzene-1,2-diaMine
|
- $318 - $776
- Product name: 5-BroMo-3,4-difluorobenzene-1,2-diaMine
- CAS: 1210048-11-5
- MF: C6H5BrF2N2
- MW: 223.02
- EINECS:
- MDL Number:MFCD22375091
- Synonyms:5-BroMo-3,4-difluorobenzene-1,2-diaMine;1,2-Benzenediamine, 5-bromo-3,4-difluoro-
5 prices
Selected condition：
Brand
- Apolloscientific
- Crysdot
- SynQuest Laboratories
Package
- 250mg
- 1g
- ManufacturerApolloscientific
- Product numberPC500007
- Product description5-Bromo-3,4-difluorobenzene-1,2-diamine
- Packaging250mg
- Price$318
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberPC500007
- Product description5-Bromo-3,4-difluorobenzene-1,2-diamine
- Packaging1g
- Price$655
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12173523
- Product description5-Bromo-3,4-difluorobenzene-1,2-diamine 95+%
- Packaging1g
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3630-B-18
- Product description5-Bromo-3,4-difluorobenzene-1,2-diamine
- Packaging250mg
- Price$376
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3630-B-18
- Product description5-Bromo-3,4-difluorobenzene-1,2-diamine
- Packaging1g
- Price$776
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Apolloscientific | PC500007 | 5-Bromo-3,4-difluorobenzene-1,2-diamine | 250mg | $318 | 2021-12-16 | Buy |
| Apolloscientific | PC500007 | 5-Bromo-3,4-difluorobenzene-1,2-diamine | 1g | $655 | 2021-12-16 | Buy |
| Crysdot | CD12173523 | 5-Bromo-3,4-difluorobenzene-1,2-diamine 95+% | 1g | $330 | 2021-12-16 | Buy |
| SynQuest Laboratories | 3630-B-18 | 5-Bromo-3,4-difluorobenzene-1,2-diamine | 250mg | $376 | 2021-12-16 | Buy |
| SynQuest Laboratories | 3630-B-18 | 5-Bromo-3,4-difluorobenzene-1,2-diamine | 1g | $776 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|